Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
In South Korea, where ENZC is the prize, articles are being written about the deal. Here`s the write up.
https://n.news.naver.com/article/009/0004862261
Dr. Chandra was answering a statement from a stockholder saying we should uplist asap. Was not giving advice. Good night. He didn`t initiate the tweet.
You`re assuming all that info. No details were release. Anyway, you and I, along with everyone who understands what they`re invested in are going to do very well. Best of success.
This is a partnership by definition. There is a signed contract by both partners. Details have not been disclosed; but Samsung is open to further their relationship as more conserved sites are identified on the 20 viruses ENZC is working on. This info is in yesterdays PR.
Agreed.
Yes, agree with your conclusion except that the CEO said no reverse split. Read my post again please. Once ENZC gets to the forefront, Brokers and Funds won`t buy stock in the open market. They`ll buy direct from the company. Right now there isn`t enough stock to go around. Best of success.
Please tell me what your qualifications are to make such a false statement?
Please let`s put the idea of a RS to rest. If there was to be one, it would have occurred when the reverse merger took place. Besides, the CEO Charles said no rs right after the merger. When ENZC starts moving way up because major funds and brokers want to get involved, the company will have to do a forward split or issue new stock. I come to this conclusion with my 40 years experience in many forms of this business.
Most certainly it is. 4th Q should be very interesting.
What I see as a very important point in today`s PR from Samsung is; This is taken from the PR.{ CURE }
Under the terms of the agreement, Samsung Biologics will provide end-to-end
CDMO services from cell line development, clinical drug substance, and drug
product manufacturing services to support IND filings for Anti-HIV and
Anti-SARS-CoV-2 Monoclonal Antibodies for the treatment of HIV and SARS-CoV-2.
In addition, there will be continuing discussions for other Monoclonal
Antibodies being developed by Enzolytics.
The Enzolytics protocol offers the opportunity to implement A.I. analysis and
provides a platform for creating multiple fully human Monoclonal Antibodies
targeting conserved immutable sites on the virus and offering a cure for these
viruses. A stable cell line will be manufactured with support from Samsung
Biologics' R&D Center in San Francisco. Its related clinical trial materials
will be manufactured at Samsung Biologics headquarters in Incheon, South
Korea.
Thanks. Big time!
I believe you`re spot on. Plus, Samsung isn`t joining up with ENZC for chump change.
I think this is the start of a beautiful relationship!
INTL on the bid.
Thank you. Perfect.
They`ve made contact last month via twitter.
They have already made contact. Ms. Woods will do her DD before a public forum on a Pink Sheet. I`m very excited.
Good night everyone.
That`s cutting to the chase alright.
I`m really interested to see if Dr. Chandra has a podcast with Cathy Wood from Ark investments. She is one the most well known fund managers. She is constantly quoted over the News wires. She is also on all the Business networks and social media. Would anyone care to speculate what happens to the price of ENZC if Cathy Woods buys it for her Fund after speaking about it in an open forum?
That`s not what I said or implied. If Lonza, Intel or any other company is in the middle of negotiations and this guy emails them saying ENZC is not legit and that he owns the patents; these companies have to stop their negotiations and find out what`s going on and what are the facts.
God`s Blessing be with you. Godspeed.
I don`t think Charles should pay this guy off. He sent emails to companies who were negotiating with ENZC. Possible partnerships. Folks, why do you think we haven`t seen a PR since July; when CC initiated the lawsuit. This guy hurt our company in it`s ability to conduct everyday business, he hurt it`s reputation and slandered the company. He hurt shareholders because of his antics; therefor keeping the price of the stock down. He didn`t negotiate in good faith. Tried to strong arm ENZC.
Yes. I see that pattern. Very interesting.
INTL is back on the bid.
The Rock (The OTC Investor)
@OtcRock
$ENZC - I am currently watching the last interview one more time and I have realized that
@drgauravchandra
actually SAID starting on min 9:30 (We have identified conserved sites for twenty infectious diseases and now we are moving forward with adding them to our IP portfolio)!
Looks like we`re close to getting news. Bids are impressive.
Thanks. I got it from here.
Thank you. At first glance I don`t see ENZC mentioned. I`ll take a closer look after I get home.
I`ve been looking for months now and can`t find the names of the folks funding the trials. Anyone have them? I`d like to have my attorney do a background check on them .Thank you.
Looks like the frenzy is over. Let`s see where we settle in.
Impressive. May have plenty of volume going into tomorrow.
I really like the volatility.
Thank you for sharing that very important piece. INTC writing up ENZC is tremendous!
Tom Nelson
@TENAssociates
$ENZC getting ready for the institutional level...
1:53 PM · Sep 28, 2021·Twitter for Android
$ENZC getting ready for the institutional level...
— TEN Associates LLC (@PWExchangeINC) September 28, 2021
Good morning. If any company decides to invest or take a position in ENZC; they will probably buy stock directly from the company from it`s treasury stock. One price, one check.
I would love to see ENZC a wholly owned subsidiary with it`s own stock symbol of INTC.
Yes, it sure would. Keeping my hopes up!